Ambarani, Anesan .
HRN: 26-30-93 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/30/2026
CEFUROXIME 1.5GM (VIAL)
03/30/2026
04/06/2026
IV
260mg
Q8h
Pcap
Checking Initial Appropriateness